Last reviewed · How we verify

NCT06718036

Validation and Evaluation of the ICF Rehabilitation Set

ENROLLING BY INVITATION Last updated 26 March 2025
What this trial tests

trial testing Validation and evaluation of the use of the ICF Rehabilitation Set in clinical practice in Chronic Disease in 200 participants. Enrolling by invitation.

Timeline
15 December 2024
Primary endpoint
15 June 2025
15 September 2025

Quick facts

Lead sponsorUniversity of Rzeszow
StatusENROLLING BY INVITATION
Study typeOBSERVATIONAL
Enrollment200
Start date15 December 2024
Primary completion15 June 2025
Estimated completion15 September 2025
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

University of Rzeszow

Who can join

Adults 18 to 65, any sex, with Chronic Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Rehabilitation is considered a key health strategy in the 21st century. The aim of rehabilitation is to optimize the functioning of patients. The International Classification of Functioning, Disability and Health (ICF) is a framework for describing and organizing information on functioning and disability. Therefore, the aim of the study is to validate and evaluate the application of the ICF Rehabilitation Set in Polish clinical practice.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Validation and evaluation of the application of the ICF Rehabilitation Set: a Polish clinical perspective.
    Wiśniowska-Szurlej A, Sozańska A, Brożonowicz J, Wilmowska-Pietruszyńska A, et al · · 2025 · PMID 40764554 · DOI 10.1186/s12913-025-13048-2

Verify or expand the search:

Other recruiting trials for Chronic Disease

Currently open trials in the same condition.

Other University of Rzeszow trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06718036.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing